Cochlear ups investment in sleep device

Hearing implant group Cochlear has increased its investment in a start-up business developing a device to combat obstructive sleep apnea. Apnea, a market dominated by Cochlear’s Australian rival ResMed, has attracted a number of competing devices with healthcare company Nyxoah pursuing a novel approach. The company’s device (pictured) stimulates the tongue nerve during sleep, triggering…

EMVision stroke detection instrument used in patient trials

Medical technology group EMVision Medical Devices (ASX: EMV) has begun clinical trials of its novel stroke detection instrument (pictured). The company announced that it had received the green light for trials which have now begun at the Princess Alexandra Hospital in Brisbane. EMVision CEO Ron Weinberger said: “Taking a prototype of our complexity from the…

Anatara Lifesciences gets good news on GaRP supplement

Anatara Lifesciences (ASX:ANR) has released encouraging pre-clinical trial data of its Gastrointestinal ReProgramming (GaRP) dietary supplement which targets diarrhoea. The company is now targeting the second half of this year for human trials of GaRP which treats underlying causes such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). “Anatara believes its GaRP dietary…

Admedus receives approval for human heart valve implants

Heart surgery product developer Admedus (ASX: AHZ) has received approvals for its first in-human trial at Leuven University Hospital of the company’s proprietary ADAPT single-piece 3D aortic valve. The Belgian surgeon Professor Bart Meuris will conduct the trial of 15 patients who will be followed up six month after receiving the ADAPT implant. Results of…

Wheezo from Respiri set to go on sale.

Respiri Limited (ASX:RSH) has achieved TGA approval to list its wheezo asthma monitoring device (pictured) on the Australian Therapeutics Goods Register (ARTG). The device is the world’s first digital wheeze monitoring solution of sensor, smartphone application and digital health platform to help people manage respiratory disease. TGA approval came after the Melbourne company undertook an…